Clinical Trials Directory

Trials / Conditions / Neurofibroma

Neurofibroma

12 registered clinical trials studyying Neurofibroma — 3 currently recruiting.

StatusTrialSponsorPhase
RecruitingFeasibility and Tolerability of IMLYGIC for the Treatment of Cutaneous Neurofibromas in Adults With NF1
NCT07102394
Johns Hopkins UniversityPhase 1
RecruitingDevelopment of Patient-Reported Outcome Measures Assessing Tumor Visibility and Appearance Concerns in Neurofi
NCT06880991
National Cancer Institute (NCI)—
CompletedPhase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent
NCT06322342
Reveal Pharmaceuticals Inc.Phase 2
Active Not RecruitingNon-interventional Study of Patients With PN NF1 Starting Selumetinib in Russia
NCT05891847
AstraZeneca—
RecruitingEvaluation of Percutaneous Cryotherapy in the Treatment of Plexiform Neurofibromas and Unresectable Neurofibro
NCT05199376
Centre Leon BerardN/A
Active Not RecruitingWhole Body MRI to Identify Atypical Neurofibromas in Patients With NF1
NCT03820778
Children's National Research InstituteN/A
WithdrawnProton Radiation Therapy for Spinal Tumors
NCT01567787
University of FloridaN/A
CompletedTopical Rapamycin Therapy to Alleviate Cutaneous Manifestations of Tuberous Sclerosis Complex (TSC) and Neurof
NCT01031901
The University of Texas Health Science Center, HoustonPhase 1
CompletedStereotactic Body Radiotherapy for Spine Tumors
NCT01347307
Mercy ResearchN/A
TerminatedPhase I Clinical Study of the Safety of Photodynamic Therapy (PDT) Using LS11 in Children With Plexiform Neuro
NCT00716469
Children's Hospital of PhiladelphiaPhase 1
Active Not RecruitingNatural History Study of Patients With Neurofibromatosis Type I
NCT00924196
National Cancer Institute (NCI)—
CompletedNatural History and Biology of Skin Neurofibromas in Neurofibromatosis Type 1
NCT00314119
National Cancer Institute (NCI)—